Literature DB >> 2557221

Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice.

K P Rigley1, M M Harnett, R J Phillips, G G Klaus.   

Abstract

CBA/N mice, which carry the xid immunodeficiency, lack a mature subpopulation of B cells. The residual B cells in these mice do not make antibodies to type-2 T-independent antigens, nor do they synthesize DNA in response to mitogenic forms of anti-Ig antibodies. It is therefore an attractive hypothesis that the surface immunoglobulin receptors (sIgR) on xid B cells signal abnormally following cross-linking. We show here that anti-Ig antibodies do cause inositol phospholipid hydrolysis and Ca2+ mobilization in xid B cells. However, the response of these cells are only 40%-50% of those of normal B cells. Studies with permeabilized cells demonstrated that the hyporesponsiveness is not due to ineffective coupling of sIgR to their associated G-protein. Rather it is apparently due to a quantitative and/or qualitative deficiency in the polyphosphoinositide-specific phosphodiesterase which mediates sIgR-induced inositol phospholipid hydrolysis. These observations may provide a biochemical explanation for the immunological abnormalities resulting from the xid mutation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557221     DOI: 10.1002/eji.1830191117

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.

Authors:  S Nisitani; R M Kato; D J Rawlings; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Btk regulates multiple stages in the development and survival of B-1 cells.

Authors:  Cristina M Contreras; Kristina E Halcomb; Lindsey Randle; Rochelle M Hinman; Toni Gutierrez; Stephen H Clarke; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2007-01-04       Impact factor: 4.407

3.  Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor.

Authors:  H Sugawara; M Kurosaki; M Takata; T Kurosaki
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

4.  Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.

Authors:  R W Hendriks; M F de Bruijn; A Maas; G M Dingjan; A Karis; F Grosveld
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

5.  Regulation of protein kinase CbetaI by two protein-tyrosine kinases, Btk and Syk.

Authors:  Y Kawakami; J Kitaura; S E Hartman; C A Lowell; R P Siraganian; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.

Authors:  C D Novina; S Kumar; U Bajpai; V Cheriyath; K Zhang; S Pillai; H H Wortis; A L Roy
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

7.  Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.

Authors:  A C Fluckiger; Z Li; R M Kato; M I Wahl; H D Ochs; R Longnecker; J P Kinet; O N Witte; A M Scharenberg; D J Rawlings
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

8.  Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome.

Authors:  H U Simon; G B Mills; S Hashimoto; K A Siminovitch
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.

Authors:  M Huber; C D Helgason; M P Scheid; V Duronio; R K Humphries; G Krystal
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

10.  The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction.

Authors:  Kazuko Saeki; Yoshiki Miura; Daisuke Aki; Tomohiro Kurosaki; Akihiko Yoshimura
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.